These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4710396)

  • 21. Coronary thromboembolism with fatal outcome following coronary angiography.
    Mogensen L; Szamosi A; Törnell G
    Acta Med Scand; 1985; 217(4):435-8. PubMed ID: 4013834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thromboembolism following coronary arteriography.
    Giddings JA; See JR; Lewis RD; Cosby RS
    Chest; 1972 Mar; 61(3):235-9. PubMed ID: 5021167
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators.
    Rogers WJ; Babb JD; Baim DS; Chesebro JH; Gore JM; Roberts R; Williams DO; Frederick M; Passamani ER; Braunwald E
    J Am Coll Cardiol; 1991 Apr; 17(5):1007-16. PubMed ID: 1901071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfemoral pulmonary angiography: update on technique.
    Grollman JH; Renner JW
    AJR Am J Roentgenol; 1981 Mar; 136(3):624-6. PubMed ID: 6781311
    [No Abstract]   [Full Text] [Related]  

  • 25. Embolic problems in angiography.
    Dawson P
    Semin Hematol; 1991 Oct; 28(4 Suppl 7):31-7; discussion 38-41. PubMed ID: 1822609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications of coronary arteriography from the Collaborative Study of Coronary Artery Surgery (CASS).
    Davis K; Kennedy JW; Kemp HG; Judkins MP; Gosselin AJ; Killip T
    Circulation; 1979 Jun; 59(6):1105-12. PubMed ID: 436203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial: Coronary arteriography. Standards of excellence for the Community Hospital.
    Manley JC
    JAMA; 1976 Feb; 235(8):846-7. PubMed ID: 1082514
    [No Abstract]   [Full Text] [Related]  

  • 28. Minimal heparinization in coronary angioplasty--how much heparin is really warranted?
    Kaluski E; Krakover R; Cotter G; Hendler A; Zyssman I; Milovanov O; Blatt A; Zimmerman E; Goldstein E; Nahman V; Vered Z
    Am J Cardiol; 2000 Apr; 85(8):953-6. PubMed ID: 10760333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Trial prevention of thrombosis with low molecular weight dextran during selective arteriography].
    Heitz F; Sotty M; Grellet J; Hubin F; Roucayrol R
    Ann Radiol (Paris); 1971; 14(5):501-10. PubMed ID: 5562778
    [No Abstract]   [Full Text] [Related]  

  • 30. Vascular access site complication in transfemoral coronary angiography between uninterrupted warfarin and heparin bridging.
    Wongcharoen W; Pinyosamosorn K; Gunaparn S; Boonnayhun S; Thonghong T; Suwannasom P; Phrommintikul A
    J Interv Cardiol; 2017 Aug; 30(4):387-392. PubMed ID: 28664579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary embolism as a complication of transfemoral arteriography--incidence, symptoms, and prevention.
    Yasuno M; Onodera T; Kawata R; Ishida M; Saito Y; Takahashi M
    Jpn Circ J; 1984 May; 48(5):439-44. PubMed ID: 6727025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential thrombogenic action of a nonionic radiographic contrast medium used during coronary angiography is offset by heparin during coronary angioplasty.
    Mukherjee M; Scully MF; Thomas M; Jewitt D; Kakkar VV
    Thromb Haemost; 1996 Nov; 76(5):679-81. PubMed ID: 8950772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Etiology and possible prevention of hemostasis-related complications in angiographies with triiodinated contrast media].
    Wamhoff D; Banzhaf E
    Z Gesamte Inn Med; 1979 Jun; 34(11):134-6. PubMed ID: 473814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indications for coronary arteriography: risks vs. benefits.
    Selzer A; Anderson WL; March HW
    Calif Med; 1971 Nov; 115(5):1-6. PubMed ID: 5117595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of thromboembolism in total hip replacement. Aspirin versus dihydroergotamine-heparin.
    Josefsson G; Dahlqvist A; Bodfors B
    Acta Orthop Scand; 1987 Dec; 58(6):626-9. PubMed ID: 3327353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of thromboembolism with low-dose heparin].
    Kussmann J
    Langenbecks Arch Chir; 1986; 369():473-8. PubMed ID: 3807565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin.
    Clarke-Pearson DL; Coleman RE; Synan IS; Hinshaw W; Creasman WT
    Am J Obstet Gynecol; 1983 Mar; 145(5):606-13. PubMed ID: 6338722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Critical and therapeutic study of local complications of retrograde arteriography. Apropos of 20 cases].
    Bigot R; Poilleux J; Monnier JP; Doyon D
    Ann Radiol (Paris); 1971; 14(5):471-80. PubMed ID: 5562774
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preoperative detection of the postoperative risk of thromboembolism. Results of a prospective study. II. Clinical results].
    Liedloff H; Heerdegen R; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):500-1. PubMed ID: 6083918
    [No Abstract]   [Full Text] [Related]  

  • 40. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.